Physician profile
Gregory M Lomas
NPI 1508967761
$4,582.20
in general payments reported to CMS, 2019-2025
34 companies · $235 in 2025
The $235 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $504 · 2020: $161 · 2021: $337 · 2022: $1,248 · 2023: $1,385 · 2024: $711 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,297 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,296.77 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $1,152.26 | 2019-2023 | Flex-X, Hopkins |
| Coloplast Corp | $540.49 | 2022-2025 | Self-Cath, Speedicath |
| Myriad Genetic Laboratories, INC. | $368.38 | 2022-2024 | Prolaris |
| Rochester Medical Corporation | $308.09 | 2020-2022 | |
| Boston Scientific Corporation | $254.37 | 2019-2025 | Spaceoar Vue System - 10ml |
| Sumitomo Pharma America, INC. | $246.14 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $219.81 | 2022-2023 | Xiaflex, Aveed, Edex |
| Abbvie INC. | $178.58 | 2022-2024 | |
| Janssen Biotech, INC. | $162.26 | 2022-2025 | Erleada |
| 180 Medical, INC. | $128.67 | 2023-2024 | Gentlecath, Gentlecath Glide |
| Merck Sharp & Dohme LLC | $123.50 | 2022-2024 | Lynparza, Keytruda, Welireg |
| Endo USA, INC. | $84.10 | 2024 | Xiaflex, Aveed, Edex |
| Astellas Pharma US INC | $79.59 | 2022-2024 | Xtandi, Veozah |
| Hollister Incorporated | $77.39 | 2022-2023 | Infyna Chic, Vapro |
| Olympus America INC. | $76.78 | 2022-2024 | Itind System |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $64.85 | 2025 | |
| Dendreon Pharmaceuticals LLC | $42.21 | 2022 | |
| Tolmar, INC. | $41.22 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.09 | 2024 | |
| Halozyme INC | $35.12 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Laborie Medical Technologies Corp. | $33.78 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Antares Pharma, INC. | $32.98 | 2024 | Xyosted |
| Myovant Sciences INC. | $30.23 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $30.02 | 2023-2024 | Bard Inlay Optima Ureteral Stent With Hydroglide Guidewire |
| Baxter Healthcare | $29.28 | 2024 | Perclot |
| Convatec INC. | $27.33 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $23.08 | 2022 | |
| Pfizer INC. | $23.03 | 2023 | |
| Urogen Pharma, INC. | $22.93 | 2023 | Jelmyto |
| Urovant Sciences INC | $21.53 | 2022 | |
| Allergan, INC. | $18.15 | 2022 | |
| Progenics Pharmaceuticals, INC. | $16.59 | 2024 | |
| Photocure INC | $13.31 | 2024 | Cysview |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Lomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.